FIELD: pharmaceutical chemistry.
SUBSTANCE: group of inventions includes a compound
,
as well as a pharmaceutical composition based on it, the use and method of treating HIV infection.
EFFECT: 3,4-dihydropyrido[2,3-d]pyrimidinyl derivative used to treat HIV infection with improved pharmacokinetic parameters.
8 cl, 1 dwg, 3 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TRANSGLUTAMINASE 2 (TG2) INHIBITORS | 2019 |
|
RU2781370C2 |
| HUMAN IMMUNODEFICIENCY VIRUS REPLICATION INHIBITORS | 2019 |
|
RU2812128C2 |
| COMPOUNDS | 2016 |
|
RU2725616C2 |
| PYRROLOPYRIDINONE DERIVATIVES AS TTX-S BLOCKERS | 2013 |
|
RU2646754C2 |
| SUBSTITUTED CARBONUCLEOSIDES DERIVATIVES USED AS ANTICANCER AGENTS | 2017 |
|
RU2712944C1 |
| TETRASUBSTITUTED ALKENE COMPOUNDS AND USE THEREOF | 2016 |
|
RU2733741C2 |
| BICYCLIC LACTAMS AND METHODS FOR USE THEREOF | 2016 |
|
RU2716136C2 |
| PYRROLOPYRAZINE KINASE INHIBITORS | 2012 |
|
RU2673064C2 |
| COMPOUNDS AND COMPOSITIONS USED FOR TREATMENT OF NTRK-RELATED DISORDERS | 2016 |
|
RU2744974C2 |
| DERIVATIVES OF 2-AMINOPYRIDINE OR 2-AMINOPYRIMIDINE AS CYCLIN-DEPENDENT KINASE INHIBITORS | 2019 |
|
RU2762557C1 |
